The Affiliated Hospital of Hangzhou Normal University — Hangzhou, Zhejiang

Public research footprint of The Affiliated Hospital of Hangzhou Normal University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease… · Nonalcoholic Steatohepatitis With Liver Fibrosis · Coronary Artery Disease · Non-alcoholic Fatty Liver Disease

Recently updated registry entries

NCT07741045 — Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients… (Not Yet Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT06990477 — Effect of EIT-guided PEEP in ARDS Patients (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Affiliated Hospital of Hangzhou Normal University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.